Sfoglia per Rivista HAEMATOLOGICA
Nails changes in onco-hematologic patients
2001-01-01 Vassallo, C; Brazzelli, V; Ardigo, M; Borroni, G
New reciprocal translocation t(5;10)(q33;q22) associated with atypical chronic myeloid leukemia
1999-01-01 Siena, S; Sammarelli, G; Grimoldi, Mg; Schiavo, R; Nozza, A; Roncalli, M; Mecucci, C; Santoro, A; Carlo Stella, C
New technology and changing parameters of leukapheresis for blood cell transplantation
1999-01-01 Granzow, K; Schiavo, R; Timofeeva, I; Moroni, G; Santoro, A; Siena, S
Outcome after allogeneic bone marrow transplantation in cytogenetic high-risk myelodysplastic syndromes and acute myeloid leukemia.
2005-01-01 DELLA PORTA, MATTEO GIOVANNI; Malcovati, Luca
Over-expression of mitochondrial ferritin affects the JAK2/STAT5 pathway in K562 cells and causes mitochondrial iron accumulation
2011-01-01 Santambrogio, Paolo; Erba, Benedetta Gaia; Campanella, Alessandro; Cozzi, Anna; Causarano, Vincenza; Cremonesi, Laura; Gallì, Anna; Della Porta, Matteo Giovanni; Invernizzi, Rosangela; Levi, Sonia
Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance.
2017-01-01 Varettoni, M; Zibellini, S; Defrancesco, I; Ferretti, Vv; Rizzo, E; Malcovati, L; Gallì, A; Della Porta, M; Boveri, E; Arcaini, L; Candido, C; Paulli, M; Cazzola, M
A pharmacological study on pegylated asparaginase used in front-line treatment of children with acute lymphoblastic leukemia
2006-01-01 Rizzari, C; Citterio, M; Zucchetti, M; Conter, V; Chiesa, R; Colombini, A; Malguzzi, S; Silvestri, D; D'Incalci, M
Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapy
2012-01-01 Devillier, Raynier; Coso, Diane; Castagna, Luca; Rossi Isabelle, Brenot; Anastasia, Antonella; Chiti, A; Ivanov, Vadim; Schiano Jean, Marc; Santoro, Armando; Chabannon, Christian; Balzarotti, Monica; Blaise, Didier; Bouabdallah, Reda
Predicting survival and leukemic evolution in patients with myelodysplastic syndrome
2006-01-01 Malcovati, Luca; DELLA PORTA, MATTEO GIOVANNI; Cazzola, Mario
PREDICTIVE VALUE OF EARLY PET DURING SALVAGE CHEMOTHERAPY IN RELAPSING/REFRACTORY HODGKIN'S LYMPHOMA (HL) PATIENTS
2008-01-01 Castagna, L; Bramanti, S; Balzarotti, M; Todisco, E; Sarina, B; Anastasia, A; Magagnoli, M; Nozza, A; Mazza, R; Giordano, L; Chiti, A; Santoro, A
Premature termination codon mutations in the von Willebrand factor gene are associated with allele-specific and position-dependent mRNA decay
2010-01-01 Platè, M; Duga, S; Baronciani, L; LA MARCA, S; Rubini, V; Mannucci, Pm; Federici, Ab; Asselta, R
Pretransplantation pet as major prognostic discriminant in IGEV-treated patients with refractory/relapsed Hodgkin's lymphoma (HL)
2007-01-01 Balzarotti, M; Magagnoli, M; Luminari, S; Spina, M; Chisesi, T; Pinto, A; Federico, M; Castagna, L; Chiti, A; Michieli, M; Angrilli, F; Marcacci, G; Minuti, F; Tirelli, U; Santoro, A
Prevalence, incidence and types of mild anemia in the elderly: the "Health and Anemia" population-based study.
2010-01-01 Tettamanti, M.; Lucca, U.; Gandini, F.; Recchia, A.; Mosconi, P.; Apolone, G.; Nobili, A.; Tallone, Mv.; Detoma, P.; Giacomin, A.; Clerico, M.; Tempia, P.; Savoia, L.; Fasolo, G.; Ponchio, L.; Riva, E.; Della Porta, Mg.
Profiling the mutational landscape of coagulation factor V deficiency.
2020-01-01 Paraboschi, E; Menegatti, M; Rimoldi, V; Borhany, M; Abdelwahab, M; Gemmati, D; Peyvandi, F; Duga, S; Asselta, R.
Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study.
2010-01-01 DELLA PORTA, MATTEO GIOVANNI
Prognostic significance of reproducible immunophenotypic markers of marrow dysplasia
2014-01-01 DELLA PORTA, MATTEO GIOVANNI
Rare variants lowering the levels of coagulation factor X are protective against ischemic heart disease
2020-01-01 Paraboschi, E; Khera, Av; Merlini, Pa; Gigante, L; Peyvandi, F; Chaffin, M; Menegatti, M; Busti, F; Girelli, D; Martinelli, N; Olivieri, O; Kathiresan, S; Ardissino, D; Asselta, R; Duga, S
Reply to: [Factor XI mutation and the origin of Ashkenazi Jews. Haematologica 2008; 93:e59]
2008-01-01 Zadra, G.; Asselta, R.; Tenchini, M. L.; Castaman, G.; Seligsohn, U.; Mannucci, P. M.; Duga, S.
Rescue of activated protein C-resistance phenotype by cis-acting factor V Gly2032Asp mutation
2004-01-01 Asselta, R; Bossone, A; Iannaccone, L; Duga, S; Brancaccio, V; Margaglione, M
Retrospective evaluation of dysifibrinogenemic patients at a single center: clinical features and laboratory findings
2009-01-01 Santoro, C; Leporace, Ap; Biondo, F; Plate, M; Asselta, R; Peyvandi, F; Menegatti, M; Pignoloni, P; Duga, S; Foa, R; Mazzucconi, Mg
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Nails changes in onco-hematologic patients | 1-gen-2001 | Vassallo, C; Brazzelli, V; Ardigo, M; Borroni, G | |
New reciprocal translocation t(5;10)(q33;q22) associated with atypical chronic myeloid leukemia | 1-gen-1999 | Siena, S; Sammarelli, G; Grimoldi, Mg; Schiavo, R; Nozza, A; Roncalli, M; Mecucci, C; Santoro, A; Carlo Stella, C | |
New technology and changing parameters of leukapheresis for blood cell transplantation | 1-gen-1999 | Granzow, K; Schiavo, R; Timofeeva, I; Moroni, G; Santoro, A; Siena, S | |
Outcome after allogeneic bone marrow transplantation in cytogenetic high-risk myelodysplastic syndromes and acute myeloid leukemia. | 1-gen-2005 | DELLA PORTA, MATTEO GIOVANNI; Malcovati, Luca | |
Over-expression of mitochondrial ferritin affects the JAK2/STAT5 pathway in K562 cells and causes mitochondrial iron accumulation | 1-gen-2011 | Santambrogio, Paolo; Erba, Benedetta Gaia; Campanella, Alessandro; Cozzi, Anna; Causarano, Vincenza; Cremonesi, Laura; Gallì, Anna; Della Porta, Matteo Giovanni; Invernizzi, Rosangela; Levi, Sonia | |
Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance. | 1-gen-2017 | Varettoni, M; Zibellini, S; Defrancesco, I; Ferretti, Vv; Rizzo, E; Malcovati, L; Gallì, A; Della Porta, M; Boveri, E; Arcaini, L; Candido, C; Paulli, M; Cazzola, M | |
A pharmacological study on pegylated asparaginase used in front-line treatment of children with acute lymphoblastic leukemia | 1-gen-2006 | Rizzari, C; Citterio, M; Zucchetti, M; Conter, V; Chiesa, R; Colombini, A; Malguzzi, S; Silvestri, D; D'Incalci, M | |
Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapy | 1-gen-2012 | Devillier, Raynier; Coso, Diane; Castagna, Luca; Rossi Isabelle, Brenot; Anastasia, Antonella; Chiti, A; Ivanov, Vadim; Schiano Jean, Marc; Santoro, Armando; Chabannon, Christian; Balzarotti, Monica; Blaise, Didier; Bouabdallah, Reda | |
Predicting survival and leukemic evolution in patients with myelodysplastic syndrome | 1-gen-2006 | Malcovati, Luca; DELLA PORTA, MATTEO GIOVANNI; Cazzola, Mario | |
PREDICTIVE VALUE OF EARLY PET DURING SALVAGE CHEMOTHERAPY IN RELAPSING/REFRACTORY HODGKIN'S LYMPHOMA (HL) PATIENTS | 1-gen-2008 | Castagna, L; Bramanti, S; Balzarotti, M; Todisco, E; Sarina, B; Anastasia, A; Magagnoli, M; Nozza, A; Mazza, R; Giordano, L; Chiti, A; Santoro, A | |
Premature termination codon mutations in the von Willebrand factor gene are associated with allele-specific and position-dependent mRNA decay | 1-gen-2010 | Platè, M; Duga, S; Baronciani, L; LA MARCA, S; Rubini, V; Mannucci, Pm; Federici, Ab; Asselta, R | |
Pretransplantation pet as major prognostic discriminant in IGEV-treated patients with refractory/relapsed Hodgkin's lymphoma (HL) | 1-gen-2007 | Balzarotti, M; Magagnoli, M; Luminari, S; Spina, M; Chisesi, T; Pinto, A; Federico, M; Castagna, L; Chiti, A; Michieli, M; Angrilli, F; Marcacci, G; Minuti, F; Tirelli, U; Santoro, A | |
Prevalence, incidence and types of mild anemia in the elderly: the "Health and Anemia" population-based study. | 1-gen-2010 | Tettamanti, M.; Lucca, U.; Gandini, F.; Recchia, A.; Mosconi, P.; Apolone, G.; Nobili, A.; Tallone, Mv.; Detoma, P.; Giacomin, A.; Clerico, M.; Tempia, P.; Savoia, L.; Fasolo, G.; Ponchio, L.; Riva, E.; Della Porta, Mg. | |
Profiling the mutational landscape of coagulation factor V deficiency. | 1-gen-2020 | Paraboschi, E; Menegatti, M; Rimoldi, V; Borhany, M; Abdelwahab, M; Gemmati, D; Peyvandi, F; Duga, S; Asselta, R. | |
Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study. | 1-gen-2010 | DELLA PORTA, MATTEO GIOVANNI | |
Prognostic significance of reproducible immunophenotypic markers of marrow dysplasia | 1-gen-2014 | DELLA PORTA, MATTEO GIOVANNI | |
Rare variants lowering the levels of coagulation factor X are protective against ischemic heart disease | 1-gen-2020 | Paraboschi, E; Khera, Av; Merlini, Pa; Gigante, L; Peyvandi, F; Chaffin, M; Menegatti, M; Busti, F; Girelli, D; Martinelli, N; Olivieri, O; Kathiresan, S; Ardissino, D; Asselta, R; Duga, S | |
Reply to: [Factor XI mutation and the origin of Ashkenazi Jews. Haematologica 2008; 93:e59] | 1-gen-2008 | Zadra, G.; Asselta, R.; Tenchini, M. L.; Castaman, G.; Seligsohn, U.; Mannucci, P. M.; Duga, S. | |
Rescue of activated protein C-resistance phenotype by cis-acting factor V Gly2032Asp mutation | 1-gen-2004 | Asselta, R; Bossone, A; Iannaccone, L; Duga, S; Brancaccio, V; Margaglione, M | |
Retrospective evaluation of dysifibrinogenemic patients at a single center: clinical features and laboratory findings | 1-gen-2009 | Santoro, C; Leporace, Ap; Biondo, F; Plate, M; Asselta, R; Peyvandi, F; Menegatti, M; Pignoloni, P; Duga, S; Foa, R; Mazzucconi, Mg |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile